Literature DB >> 8099750

Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings.

W K Chong1, B Sweeney, I D Wilkinson, M Paley, M A Hall-Craggs, B E Kendall, J K Shepard, M Beecham, R F Miller, I V Weller.   

Abstract

Abnormalities at cerebral proton spectroscopy occur in patients with the acquired immunodeficiency syndrome (AIDS). N-acetyl aspartate (NAA) is believed to be a neuronal marker, and neuronal loss is thought to underlie the human immunodeficiency virus (HIV)-associated cognitive/motor complex. The proton spectra in 103 HIV-seropositive patients and 23 control subjects were compared and correlated with clinical, immunologic, and radiologic measures of HIV infection. Significant (P < .05) reductions in the mean NAA/choline (Cho) and NAA/creatine (Cr) ratios were seen in patients with immune suppression and neurologic signs. Significant increases in the Cho/Cr ratios were seen in patients with low CD4 lymphocyte counts and abnormal magnetic resonance (MR) images. Reduced NAA ratios correlated with diffuse but not focal MR imaging abnormalities. Combined MR imaging and spectroscopy provides closer relationships to clinical and immunologic measures of disease than either modality alone. Spectroscopy is an adjunct to MR imaging and augments the value of an MR imaging study.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099750     DOI: 10.1148/radiology.188.1.8099750

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  40 in total

Review 1.  Human immunodeficiency virus-associated dementia: an evolving disease.

Authors:  Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

Review 2.  The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections.

Authors:  David F Tate; Rola Khedraki; Daniel McCaffrey; Daniel Branson; Jeffrey Dewey
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

3.  Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy.

Authors:  D López-Villegas; R E Lenkinski; I Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

4.  Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.

Authors:  Alan Winston; Chris Duncombe; Patrick C K Li; John M Gill; Stephen J Kerr; Rebekah L Puls; Simon D Taylor-Robinson; Sean Emery; David A Cooper
Journal:  Neuroradiology       Date:  2012-07-07       Impact factor: 2.804

5.  Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS.

Authors:  Kenneth Williams; Susan Westmoreland; Jane Greco; Eva Ratai; Margaret Lentz; Woong-Ki Kim; Robert A Fuller; John P Kim; Patrick Autissier; Prahbat K Sehgal; Raymond F Schinazi; Norbert Bischofberger; Michael Piatak; Jeffrey D Lifson; Eliezer Masliah; R Gilberto González
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

6.  JC virus infection of the brain.

Authors:  A K Bag; J K Curé; P R Chapman; G H Roberson; R Shah
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

7.  Proton MRS and quantitative MRI assessment of the short term neurological response to antiretroviral therapy in AIDS.

Authors:  I D Wilkinson; S Lunn; K A Miszkiel; R F Miller; M N Paley; I Williams; R J Chinn; M A Hall-Craggs; S P Newman; B E Kendall; M J Harrison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

8.  Spatial data analysis in the quantitative assessment of cerebral white matter pathology on MRI in HIV infection.

Authors:  R J Corrigall; W K Chong; M Paley; I D Wilkinson; P Lantos; I Everall
Journal:  Neuroradiology       Date:  1995-08       Impact factor: 2.804

9.  Evidence of CNS impairment in HIV infection: clinical, neuropsychological, EEG, and MRI/MRS study.

Authors:  M J Harrison; S P Newman; M A Hall-Craggs; C J Fowler; R Miller; B E Kendall; M Paley; I Wilkinson; B Sweeney; S Lunn; S Carter; I Williams
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-09       Impact factor: 10.154

10.  Neuropsychological function and cerebral metabolites in HIV-infected youth.

Authors:  R Nagarajan; M K Sarma; M A Thomas; L Chang; U Natha; M Wright; J Hayes; K Nielsen-Saines; D E Michalik; J Deville; J A Church; K Mason; T Critton-Mastandrea; S Nazarian; J Jing; M A Keller
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-13       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.